Clinical Trials Sponsored by Sofya Pintova

Total 277 results

Sofya Pintova
DSM Nutritional Products, Inc.

Completed

Genistein in Treatment of Metastatic Colorectal Cancer

Colorectal Cancer | Rectal Cancer | Colon Cancer

United States
Sofia Med Hospital

Active, not recruiting

LESS TEP vs. Three Port TEP for Inguinal Hernia Repair

Inguinal Hernia

Bulgaria
Hospital Infanta Sofia

Completed

High-flow Conditioned Oxygen Therapy Versus Non-invasive Ventilation: Prevention of Post-extubation Failure

Post-extubation Respiratory Failure

Spain
Sofia Med Hospital

Completed

Corona Mortis in Patients Undergoing TEP for Inguinal Hernia

Inguinal Hernia | Bleeding | Pelvic Fracture | Acetabular Fracture

Bulgaria
Hospital Infanta Sofia

Completed

Improving Arteriovenous Fistula Patency (METTRO)

Thrombosis

Spain
Medical University of Sofia

Completed

Therapeutic Efficacy of Orbital Radiotherapy in Patients With Graves' Orbitopathy

Graves Ophthalmopathy

Bulgaria
Medical University of Sofia

Completed

Comparison of the Effectiveness of Two Glucocorticoid Regimens for Treatment of Graves' Orbitopathy

Graves Ophthalmopathy

Bulgaria
Halmstad University
Vinnova

Completed

A Mobile App for Medication Adherence in Persons With Hypertension: a Pilot Study

Hypertension

Sweden
Attgeno AB
Vinnova

Withdrawn

A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in COVID-19 Patients With Acute Pulmonary Hypertension

COVID-19 | Pulmonary Hypertension

Sweden
Sofia Ryman Augustsson

Completed

Injuries in Swedish Padel

Injury;Sports

Sweden
Sofia Ramström

Enrolling by invitation

Transfusion of Whole Blood in Acute Bleeding (HEPEP)

Blood Transfusion | Acute Bleeding

Sweden
Xintela AB
Vinnova

Recruiting

A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers

Venous Leg Ulcer

Sweden
Region Skane
Vinnova

Completed

PHMB-based Antiseptic Use in Full-thickness Surgical Wounds

Surgical Site Infections

Sweden
Lund University
Vinnova

Completed

An Antiinflammatory Diet as Modulator of Cardiometabolic Risk and Body Weight in Healthy Subjects

Overweight | Metabolic Syndrome | Insulin Resistance

Sweden
Sofia Ramström

Enrolling by invitation

Function of Platelets Used for Transfusions

Thrombocytopenia | Hematologic Malignancy

Sweden
Hinova Pharmaceuticals Aus Pty Ltd

Completed

A Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in Patients With Metastatic Castration-Resistant Prostate Cancer

Metastatic Castration-resistant Prostate Cancer

Australia
Innova Vascular, Inc.

Not yet recruiting

Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST) (TRUST)

Pulmonary Embolism
Hinova Pharmaceuticals Inc.

Completed

A Study Evaluating HC-1119 Single-Dose Pharmacokinetics and Effect of Food on Its Pharmacokinetics

Metastatic Castration Resistant Prostate Cancer

China
Hinova Pharmaceuticals Inc.

Completed

A Study Evaluating Enzalutamide Pharmacokinetics and Pharmacodynamics, and Related Changes After Drug Switch

Metastatic Castration Resistant Prostate Cancer

China
Hospital Universitario Reina Sofia de Cordoba

Completed

Effectiveness of a Cream for Treatment of Dermatitis in Patients Whith Breast Cancer (Alantel)

DERMATITIS INDUCED BY RADIOTHERAPY IN PATIENTS WHITH BREAST CANCER

Spain
Hospital Universitario Reina Sofia de Cordoba

Completed

Comparison of Two Techniques for the Treatment of Carpal Tunnel Syndrome (STCCOT)

Carpal Tunnel Syndrome

Spain
Mofya Diallo

Withdrawn

Remifentanil-dexmedetomidine Anesthesia With a Caudal for Elective Surgery. (Remi-dex) (Remi-dex)

Anesthesia
Hinova Pharmaceuticals Inc.

Recruiting

A Trial Evaluating the Efficacy and Safety of HC-1119 Soft Capsules in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC).

mCRPC

China
Hospital Universitario Reina Sofia de Cordoba

Recruiting

Retroversion in Reverse Shoulder Arthroplasty (RV-RSA)

Shoulder Osteoarthritis

Spain
Hospital Universitario Reina Sofia de Cordoba

Completed

CORonary Diet Intervention With Olive Oil and Cardiovascular PREVention (CORDIOPREV)

Myocardial Infarction | Diabetes Mellitus | Metabolic Syndrome | Cognitive Decline | Unstable Angina | Malignancy

Spain
Hospital Universitario Reina Sofia de Cordoba

Completed

Hemo Filtration Reinfusion (HFR) Clearance Efficiency Towards P-bound Toxins and Effects on Inflammatory and Endothelial Damage Markers (SUPREMO)

Inflammation

Spain
Ospedale "Carlo Poma" - Mantova

Completed

Experimental Study About Physiotherapy Treatment vs Self-treatment In Axillary Web Syndrome After Axillary Dissection

Breast Neoplasms

Italy
Pinta Biotherapeutics

Completed

Effects of PINTA 745 in End Stage Renal Disease (ESRD) Patients Who Require Hemodialysis and Have Protein Energy Wasting

End Stage Renal Disease | Kidney Disease | Protein Energy Wasting

United States
Hinova Pharmaceuticals Inc.

Recruiting

A Phase I Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in mCRPC Patients

Metastatic Castration-resistant Prostate Cancer

China
Hospital Universitario Reina Sofia de Cordoba

Completed

New Therapeutic Approach in Upper Limb Lymphedema Secondary to Breast Cancer: Activity-oriented Proprioceptive Antiedema Therapy (TAPA)

Breast Cancer Lymphedema | Post-Mastectomy Secondary Lymphedema

Spain
Hospital General Universitario Reina Sofía de Murcia

Active, not recruiting

Ligation of Intersphincteric Fistula Tract Versus Rectal Advancement Flap in the Treatment of Complex Anal Fistula (LIFTRAF-RCT)

Anal Fistula
Centro Medico Campinas
Hospital Santa Sofia Ltda

Completed

Performance of Two Different ke0s in the Same Pharmacokinetic Propofol Model

Unconsciousness

Brazil
Bio-innova Co., Ltd

Not yet recruiting

Sacubitril 97 mg and Valsartan 103 mg Film-coated Tablets Relative to Entresto 97 mg/103 mg Film-coated Tablets

Healthy Subjects
Bio-innova Co., Ltd

Not yet recruiting

Esomeprazole Magnesium Dihydrate 40 mg Tablets Relative to Nexium 40 mg Tablets Under Fasting Condition

Healthy Subjects
Bio-innova Co., Ltd

Not yet recruiting

Sitagliptin and Metformin Hydrochloride Tablets 50 mg/500 mg Relative to Originator

Healthy Subjects
Sofia Pavanello
Mibelle AG

Recruiting

Effects of Monarda Didyma Extract Supplementation on Biological Ageing (EMODISU)

Aging

Italy
Bio-innova Co., Ltd

Not yet recruiting

Vildagliptin and Metformin Tablets 50/1000 mg Relative to GALVUS MET (50mg/1000 mg) Tablets

Healthy Subjects
Bio-innova Co., Ltd

Not yet recruiting

Nebivolol Tablets 5 mg Relative to Nebilet Tablets 5 mg

Healthy Subjects
Bio-innova Co., Ltd

Recruiting

Drospirenone (3 mg) + Ethinyl Estradiol (0.02 mg) Tablets Relative to Yaz®

Healthy Subjects

Thailand
Bio-innova Co., Ltd

Not yet recruiting

Desogestrel Tablets (0.075 mg) Relative to Originator Desogestrel Tablets (0.075 mg)

Healthy Subjects
Bio-innova Co., Ltd

Not yet recruiting

Febuxostat 80 mg Tablets Relative to Feburic® 80 mg Tablets

Healthy Subjects
Bio-innova Co., Ltd

Not yet recruiting

Esomeprazole Magnesium Dihydrate 40 mg Tablets Relative to Nexium 40 mg Tablets Under Fed Condition

Healthy Subjects
Bio-innova Co., Ltd

Not yet recruiting

Empagliflozin 10 mg Tablets Relative to Jardiance 10 mg

Healthy Subjects
Mälardalen University
Danderyd Hospital; Vinnova

Completed

Mental Imagery Neurofeedback in Strokerehabilitation

Stroke | Hemiparesis

Sweden
Inova Fairfax Hospital

Recruiting

Erythromycin Versus Azithromycin for Preterm Prelabor Rupture of Membranes (PRACET)

Premature Rupture of Membrane

United States
Bio-innova Co., Ltd

Not yet recruiting

Sildenafil 100 mg Tablets Relative to Viagra 100 mg Tablets

Healthy Subjects
Bio-innova Co., Ltd

Not yet recruiting

Dutasteride Soft Capsule 0.5 mg Relative to Avodart 0.5 mg Soft Capsule

Healthy Subjects
Bio-innova Co., Ltd

Not yet recruiting

Drospirenone (3 mg) + Ethinyl Estradiol (0.03 mg) Tablets Relative to Yasmin®

Healthy Subjects
Bio-innova Co., Ltd

Not yet recruiting

Dapagliflozin Tablet 10 mg Relative to Forxiga® Tablets 10 mg (DAP-030-23)

Healthy Subjects
Bio-innova Co., Ltd

Not yet recruiting

Ticagrelor Tablets 90 mg Relative to Originator Ticagrelor Tablets 90 mg (TIC-025-23)

Healthy Subjects

3

Subscribe